Impact of hemoglobin A1c level on the association between non-steroidal anti-inflammatory drug use and cardiovascular events in patients with type 2 diabetes: A population-based cohort study.
Kasper BonnesenLars PedersenVera EhrensteinHenrik T SørensenTimothy L LashMorten SchmidtPublished in: Pharmacoepidemiology and drug safety (2023)
In patients with type 2 diabetes, glycemic dysregulation did not affect the cardiovascular risk associated with NSAID use.